Kimberly E. Vanover
Corporate Officer/Principal bei ITI, Inc. (New York)
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sharon Mates | M | 71 |
Intra-Cellular Therapies, Inc. /Old/
 Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 22 Jahre |
| Lawrence Hineline | M | 67 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 22 Jahre |
| Michael Rawlins | M | 82 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 1 Jahre |
| Chris D. Alafi | M | 60 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 11 Jahre |
| Allen A. Fienberg | M | 64 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 12 Jahre |
| Lawrence P. Wennogle | M | 74 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 11 Jahre |
| Rory Riggs | M | 71 |
ITI, Inc. (New York)
| 10 Jahre |
| Lin-Tsing Yu | M | 80 |
University of California San Diego
| 30 Jahre |
| Joel Marcus | M | 76 |
ITI, Inc. (New York)
| 18 Jahre |
| Robert van Nostrand | M | 67 |
ITI, Inc. (New York)
| 10 Jahre |
| Michael Halstead | M | 51 |
ITI, Inc. (New York)
| 10 Jahre |
| Tony Chou | M | 63 |
University of California San Diego
| 30 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Uli Alf Hacksell | M | 74 | 15 Jahre | |
| Mark R. Brann | M | - | 13 Jahre | |
| Mary Gray | M | 71 | 11 Jahre | |
| Michael T. Borer | M | 65 | 11 Jahre | |
| Lotte Sønderbjerg | F | 62 | 7 Jahre | |
| Thomas Miller | M | 69 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 Jahre |
| Glenn F. Baity | M | 54 | 14 Jahre | |
| Richard Alan Lerner | M | 85 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | 11 Jahre |
| Gordon Binder | M | 88 | 6 Jahre | |
| Ed Wagner | M | - |
University of California San Diego
| 5 Jahre |
| Greg Little | M | - |
University of California San Diego
| 5 Jahre |
| James H. Coleman | M | 82 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | - |
| Joseph Peter Traba | M | - |
University of California San Diego
| 5 Jahre |
| David Brian Fick | M | - |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 7 Jahre |
| F. Mitchell Thrower | M | - |
University of California San Diego
| 2 Jahre |
| Ryan Heine | M | - |
University of California San Diego
| 4 Jahre |
| Christie M. Whitney | F | - |
University of California San Diego
| 4 Jahre |
| Kenneth G. Kilpo | M | - |
University of California San Diego
| 1 Jahre |
| Jeff Schlosser | M | - |
University of California San Diego
| 4 Jahre |
| Jeff Stone | M | - |
University of California San Diego
| 4 Jahre |
| Martin Basuki Hartono | M | 50 |
University of California San Diego
| 2 Jahre |
| Greg Young | M | - |
University of California San Diego
| 4 Jahre |
| Chia-Lin Simmons | M | 51 |
University of California San Diego
| 4 Jahre |
| Adam Berry | M | 50 |
University of California San Diego
| 4 Jahre |
| Michael Ian Waterman | M | - |
University of California San Diego
| 4 Jahre |
| Daniel Riskin | M | - |
University of California San Diego
| 5 Jahre |
| Darren Sherman | M | 52 |
University of California San Diego
| 6 Jahre |
| Jeannette V. Filippone | F | - |
University of California San Diego
| 1 Jahre |
| Lisa Alonso | F | 47 |
University of California San Diego
| 4 Jahre |
| Marcos Rivera | M | - |
University of California San Diego
| 4 Jahre |
| Hanny Jahja | F | - |
University of California San Diego
| 4 Jahre |
| Kyri van Hoose | M | - | 11 Jahre | |
| Firas M Rahhal | M | - |
University of California San Diego
| 2 Jahre |
| Allison Hushek | F | - |
University of California San Diego
| 4 Jahre |
| Phil Yphantides | M | - |
University of California San Diego
| 3 Jahre |
| Thomas Castleberry | M | - |
University of California San Diego
| 4 Jahre |
| Bjorn Markus Jakobsson | M | - |
University of California San Diego
| 3 Jahre |
| Ed Ruth | M | - |
University of California San Diego
| 4 Jahre |
| Jason Childers | M | - |
University of California San Diego
| 4 Jahre |
| Bryan Hall | M | - |
University of California San Diego
| 4 Jahre |
| Andreas Gottschling | M | 57 |
University of California San Diego
| 3 Jahre |
| Ophir Gottlieb | M | - |
University of California San Diego
| 4 Jahre |
| Joe Haimowitz | M | - |
University of California San Diego
| 3 Jahre |
| Dan Mytels | M | - |
University of California San Diego
| 5 Jahre |
| May D. Lee | M | - |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | - |
| Dong Ping Luo | M | 59 |
University of California San Diego
| 1 Jahre |
| Richard L. Sowers | M | 51 |
University of California San Diego
| 4 Jahre |
| Marsha Otto Riley | F | - |
University of California San Diego
| 2 Jahre |
| S. Kondragunta | M | - |
University of California San Diego
| 2 Jahre |
| Edward P. Monaghan | M | - |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | - |
| Stephanie Tran | F | - |
University of California San Diego
| 4 Jahre |
| Bo-Ragnar Tolf | M | 74 | - | |
| Vikram K. Srimurthy | M | - |
University of California San Diego
| 4 Jahre |
| Martin D. Williams | M | 58 |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | 2 Jahre |
| Robert Davis | M | 73 | 5 Jahre | |
| Nima Shiva | M | - |
University of California San Diego
| 4 Jahre |
| Brian Lundstrom | M | 61 | 5 Jahre | |
| David R. Bethune | M | 83 |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | 3 Jahre |
| David A. H. Lee | M | 74 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 5 Jahre |
| Leonard R. Borrmann | M | 66 | 2 Jahre | |
| Alan G. Walton | M | 87 | 7 Jahre | |
| Edward V. Fritzky | M | 73 |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | 5 Jahre |
| Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 Jahre |
| Thomas Kammeyer | M | - |
University of California San Diego
| 3 Jahre |
| Bob Holmen | M | 60 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 Jahre |
| Charles Homcy | M | 75 |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | 4 Jahre |
| Ben Block | M | - |
University of California San Diego
| 4 Jahre |
| Shah Badkoubei | M | - |
University of California San Diego
| 4 Jahre |
| Chris D. Emery | M | - |
University of California San Diego
| 4 Jahre |
| James E. Barrett | M | 81 |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | 3 Jahre |
| Martinus Adrianus van Osch | M | - | - | |
| Douglas Scott Wieland | M | 64 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 7 Jahre |
| Andreas Brandstetter | M | 55 |
University of California San Diego
| 3 Jahre |
| Andrew H. Gross | M | - |
University of California San Diego
| 3 Jahre |
| Andy Katz | M | - |
University of California San Diego
| 3 Jahre |
| Roger G. Mills | M | 67 | 9 Jahre | |
| Robert G. Anfuso | M | - |
University of California San Diego
| 4 Jahre |
| Steve Crawford | M | 53 |
University of California San Diego
| 1 Jahre |
| M. Hinshaw | M | - |
University of California San Diego
| 2 Jahre |
| Gary Seelhorst | M | 52 |
University of California San Diego
| 4 Jahre |
| David Spitz | M | 51 |
University of California San Diego
| 5 Jahre |
| Tim Barrett | M | - |
University of California San Diego
| 3 Jahre |
| Steven A. Yon | M | - |
University of California San Diego
| 3 Jahre |
| Jasmine Karsono | M | - |
University of California San Diego
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 96 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kimberly E. Vanover
- Persönliches Netzwerk
